2025. Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials. Magna Neurologica. 3, 2 (Jul. 2025), 138–149. DOI:https://doi.org/10.20961/magnaneurologica.v3i2.1929.